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In an effort to probe whether the metal content of metallo-β-lactamase L1 is affected by metal ion 
bioavailability, L1 was overexpressed as mature protein (M-L1) and full-length (FL-L1) analogues, and the 
analogues were characterized with metal analyses, kinetics, and EPR spectroscopy. FL-L1, containing the 
putative leader sequence, was localized in the periplasm of Escherichia coli and shown to bind Zn(II) 
preferentially. The metal content of FL-L1 could be altered if the enzyme was overexpressed in minimal medium 
containing Fe and Mn, and surprisingly, an Fe-binding analogue was obtained. On the other hand, M-L1, lacking 
the putative leader sequence, was localized in the cytoplasm of E. coli and shown to bind various amounts of Fe 
and Zn(II), and like FL-L1, the metal content of the resulting enzyme could be affected by the amount of metal 
ions in the growth medium. L1 was refolded in the presence of Fe, and a dinuclear Fe-containing analogue of L1 
was obtained, although this analogue is catalytically inactive. EPR spectra demonstrate the presence of an 
antiferromagnetically coupled Fe(III)Fe(II) center in Fe-containing L1 and suggest the presence of a Fe(III)Zn(II) 
center in M-L1. Metal analyses on the cytoplasmic and periplasmic fractions of E. coli showed that the 
concentration of metal ions in the periplasm is not tightly controlled and increases as the concentration of metal 
ions in the growth medium increases. In contrast, the concentration of Zn(II) in the cytoplasm is tightly 
controlled while that of Fe is less so. 
Bacterial resistance to β-lactam containing antibiotics such as penicillins, cephalosporins, and carbapenems is 
most often accomplished by expression of β-lactamases, which hydrolyze the C−N bond of these antibiotics (1-
4). A majority of these β-lactamases utilizes an active site serine group for the nucleophilic attack on the β-
lactam carbonyl, and the serine β-lactamases have been studied extensively for many years (4). On the other 
hand, one class (class B) of β-lactamases utilizes a metal-assisted hydrolysis pathway to inactivate β-lactam 
containing antibiotics, and these enzymes are called metallo-β-lactamases (mβl’s) (1, 2, 5-7). The mβl’s have 
been further divided into subgroups based on sequence identity, Zn(II) content, substrate preference, and 
biochemical properties. Subgroup B1 enzymes require 2 Zn(II) ions for full catalytic activity, exhibit kinetic 
preference for penicillins as substrates, exhibit >23% sequence identity toward other subgroup B1 members, 
and are represented by mβl’s CcrA from Bacteroides fragilis, BcII from Bacillus cereus, and IMP-1 from various 
sources (1, 5). Subgroup B2 enzymes require only 1 Zn(II) ion for full catalytic activity, preferentially hydrolyze 
carbapenems, exhibit 11% sequence identity with the subgroup B1 enzymes, and are represented by mβl’s ImiS 
from Aeromonas sobria and CphA from Aeronomas hydrophila(1, 5). Subgroup B3 enzymes require 2 Zn(II) ions 
for full activity, exhibit a kinetic preference for penicillins, contain only 9 conserved residues with the subgroup 
B1 enzymes, and are represented by mβl’s L1 from Stenotrophomonas maltophilia and FEZ-1 from Legionella 
gormanii(1, 5). Extensive structural and mechanistic studies have been reported on certain mβl’s, and several 
studies reporting nonclinical inhibitors have been reported. 
β-Lactam-containing antibiotics are antibacterial because these drugs inactivate transpeptidase, which is an 
enzyme that catalyzes the cross-linking of peptidoglycan building blocks to form part of the bacterial cell 
wall (4). In order to interact with transpeptidase in Gram-negative bacteria, β-lactam containing antibiotics must 
be able to cross the outer membrane and be present in the periplasm (8). Likewise, β-lactamases must be 
exported into the extracellular space in Gram-positive bacteria or into the periplasm in Gram-negative bacteria 
in order to interact and inactivate the β-lactam containing antibiotics. To mimic the physiological situation, most 
recombinant mβl’s are expressed into the periplasm of Escherichia coli by the addition of fusion tags or leader 
sequences, and most of the resulting recombinant enzymes have been shown to bind Zn(II) after isolation (1, 5, 
7). 
Despite significant amino acid sequence divergence, mβl’s contain an αββα motif, and the Zn(II) ions bind in a 
pocket contained in the ββ interface (1, 5, 7). For the B1 and B3 mβl’s, one of the Zn(II) ions binds to a site 
(called Zn1 site), in which three histidine residues and the bridging hydroxide serve as metal binding ligands. In 
all three classes of mβl’s, Zn(II) binds to a site (called Zn2 site) made up of one aspartic acid, one histidine, one 
histidine/cysteine, the bridging hydroxide, and a terminally bound water molecule. Previous modeling, 
mechanistic, and structural studies have suggested that the β-lactam carbonyl interacts with the Zn(II) in the 
Zn1 site (or residues in the Zn1 site for the B2 mβl’s), while the lone pair electrons on the β-lactam nitrogen 
coordinate metal ion in the Zn2 site (9-13). 
The αββα tertiary fold motif is called the metallo-β-lactamase fold, and there is an increasing number of 
proteins that contain this motif, including rubredoxin oxidoreductase (ROO), glyoxalase II, arylsulfatase, cAMP 
phosphodiesterase, and tRNA maturase (5). The most common metal ion found in these proteins is Zn(II); 
however, glyoxalase II has been reported to bind Fe, Zn, and Mn (14-16), and ROO has been reported to be a 
dinuclear Fe protein (17). In addition, Vila and co-workers recently reported that metallo-β-lactamase GOB 
from E. meningoseptica when overexpressed as a GST-fusion construct and folded in the cytoplasm of E. coli is 
isolated containing various amounts of Zn(II) and iron (18). These results suggest that the localization where a 
protein is folded (cytoplasm or periplasm) and the bioavailability of the metal ions in that location play a role in 
which metal ions bind to recombinant proteins. To test this suggestion, we constructed an overexpression 
plasmid for full-length L1 that contains the S. maltophilia leader sequence (FL-L1) and a plasmid containing 
mature L1 that lacked the S. maltophilia leader sequence (M-L1). The resulting overexpression plasmids were 
used to produce L1, and the FL-L1 and M-L1 were characterized using metal analyses, steady-state kinetics, and 
spectroscopic studies. 
Materials and Methods 
Cloning 
Forward primer, 5′-AAAAA CAT ATG GCC GAA GTA CCA CTG CCG C, and reverse primer, 5′-AAAAA AAG CTT AGC 
GGG CCC CG, were purchased from Integrated DNA Technologies. The PCR reactions were carried out with the 
following conditions: 95 °C, 90 s; 95 °C, 30 s; 55.5 °C, 30 s; 72 °C, 60 s; 25 cycles. The gel-purified PCR product 
and pET26b (Novagen) plasmid were digested with NdeI and HindIII according to manufacturer’s instructions. 
The gene that encodes for L1 was ligated into pET26b, and the resulting plasmid (pM-L1) was transformed 
into E. coli DH5α and confirmed with DNA sequencing. The pM-L1 plasmid was transformed into E. 
coli BL21(DE3)pLysS cells, and the resulting cells were used for overexpression studies. 
Antimicrobial Susceptibility Assay 
The in vitro activity of ampicillin against L1 (FL-L1, full-length L1) and truncated-L1 (M-L1, mature L1) that was 
overexpressed in E. coli BL21(DE3) cells was determined by a disk diffusion susceptibility test. Bacterial cultures 
were grown to midlog phase, and protein production was induced by making the cultures 1 mM in 
IPTG.1 Cultures were then grown approximately 3 h, and disk diffusion testing was performed by the NCCLS 
methodology on Mueller−Hinton agar (Becton-Dickinson) plates (National Committee for Clinical Laboratory, 
1997, Performance standards for antimicrobial disk susceptibility tests; approved standard M2-A6. National 
Committee for Clinical Laboratory Standards, Wayne, PA). Culture plates were incubated for 16 h, and the zone 
diameter sizes were measured. Periplasmic and cytoplasmic accumulation of L1 in both cultures was confirmed 
by fractionating cytoplamsic and periplasmic components using a PeriPreps periplasting kit (Epicenter, Madison, 
WI). 
Abbreviations: ICP-AES, inductively coupled plasma atomic emission spectroscopy; IPTG, isopropyl β-d-
thiogalactopyranoside; Gdn-HCl, guanidinium chloride; Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid; FPLC, fast performance liquid chromatography; LB, Luria−Bertani; MALDI-TOF MS, matrix-assisted laser 
desorption ionization mass spectrometry; PBS, phosphate-buffered saline; TAT, twin arginine transport. 
Overexpression and Purification of L1 
A 50 mL overnight preculture of BL21(DE3) E. coli cells containing the pET26b-based plasmid that encodes for M-
L1 or FL-L1 was used to innoculate 4 × 1 L flasks of LB or minimal medium, and the resulting culture was grown 
at 37 °C with shaking until the culture reached an optical density at 600 nm of 0.6−0.8. The cultures were then 
cooled to 15 °C for 30 min, made 0.5 mM in IPTG, and shaken overnight at 15 °C (roughly 16 h). For cultures to 
which metal ions were added, the metal ions were added at the same time as IPTG was added. The culture was 
centrifuged for 15 min (8200g), and the resulting cell pellet was resuspended in 50 mM Hepes, pH 6.0 (buffer A). 
The cells were lysed by passing the resuspended cells through a French press three times at a pressure of 
1000−1500 psi. After removal of insoluble components by centrifugation (25 min at 23400g), the supernatant 
was dialyzed versus buffer A overnight. The dialyzed protein solution was centrifuged (25 min at 23400g) and 
subjected to FPLC as previously reported (19). The FPLC fractions were analyzed using SDS−PAGE gels, and 
protein bands thought to contain L1 were subjected to in-gel trypsin digestions and peptide identifications using 
MALDI-TOF mass spectrometry, as previously reported (20). 
Preparation of Metal-Free (Apo) L1 
A concentrated solution of L1 (∼ 0.3 mM) was dialyzed against 4 × 1 L of 50 mM Hepes, pH 7.0, containing 10 
mM 1,10-phenanthroline and then dialyzed against 6 × 1 L of 50 mM Hepes, pH 7.0. The metal content of the 
resulting sample was ascertained by ICP-AES, as previously reported (21). The sample was stored in a −80 οC 
freezer. 
In Vitro Unfolding and Refolding of L1 
Apo-L1 (2 mL, 100 μM) was unfolded in 18 mL of 6 M guanidinium chloride (Gdn-HCl). The sample was incubated 
on ice for 1 h and then dialyzed versus 1 L of 50 mM Hepes, pH 7.0, containing no added metal, 50 μM Fe(II), 
Mn(II), or Zn (II) or Fe(II) and Zn(II). Refolded L1 was further dialyzed versus 5 × 1 L of Chelex-treated, 50 mM 
Hepes, pH 7.0, to remove any unbound metals and remaining Gdn-HCl. The resulting solution was centrifuged 
(25 min at 23400g) to remove any precipitates. 
Steady-State Kinetics 
Steady-state kinetic studies were performed on an Agilent 8453A UV−vis diode array spectrophotometer at 25 
°C using nitrocefin as the substrate and 50 mM cacodylate, pH 7.0, as the buffer. 
EPR Spectroscopy 
EPR spectra were recorded using a Bruker E600 EleXsys spectrometer equipped with an Oxford Instruments 
ESR900 helium flow cryostat and ITC503 temperature controller and an ER4116DM cavity operating at 9.63 GHz 
in perpendicular mode. Other recording parameters are given in the figure legends. Quantitation of signals was 
carried out by double integration of spectra recorded under nonsaturating conditions at 10−12 K. A 2 mM Cu(II)-
EDTA standard in Hepes, pH 7.5, recorded at 60 K, 50 μW, was used. Integration limits and correction factors 
for S = 1/2 and S = 5/2 signals where D is assumed to be small compared to temperature, as employed 
elsewhere (22) and recently described explicitly by Bou-Abdallah and Chasteen and references therein (23, 24). 
Metal Content in Cytoplasm and Periplasm of E. coli Cells 
E. coli BL21 cells were cultured in M9 minimal medium containing no added metal ions or 100 μM Zn(II), Fe(II), 
or Mn(II) until reaching an optical density at 600 nm of 1.0. The cells were collected by centrifugation (8 min at 
6000g). The resulting cell pellets were washed twice with 5 mL of PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM 
KH2PO4,7.7 mM Na2HPO4, pH 7.4), and cytoplasmic fractions were separated from periplasmic components of 
the cell using a PeriPreps periplasting kit (Epicenter, Madison, WI) according to manufacturer’s instructions. The 
metal content of the cytoplamsic/periplasmic fractions of the cells was measured using ICP-AES, as previously 
reported (21). 
Results 
S. maltophilia Leader Sequence Leads to L1 Being Exported to and Folded in the 
Periplasm of E. coli 
The gene for metallo-β-lactamase L1 from pathogen S. maltophilia encodes for a 290 amino acid protein that 
contains a 21 amino acid (MRSTLLAFALAVALPAAHTSA) leader sequence (25), which presumably targets the 
protein for export into and folding in the periplasm, and a 269 amino acid mature peptide containing the N-
terminus of AEVPLPQ (19). To determine if the leader sequence from S. maltophilia is recognized by E. coli and 
used to target L1 for export into the periplasm, we generated a pET26b-based overexpression plasmid 
containing the L1 gene lacking the leader sequence (M-L1) and used this plasmid to overexpress L1. The 
overexpression plasmid containing the gene for L1 and the leader sequence (FL-L1) has previously been 
reported (19) and was used as a control in these studies. Both overexpression plasmids were transformed into E. 
coli BL21(DE3)pLysS cells, and M-L1 and FL-L1 were overexpressed. The periplasmic fraction of each cell culture 
was obtained using the PeriPreps periplasting kit according to manufacturer’s instructions. An SDS−PAGE gel 
(Figure 1A), followed by in-gel trypsin digestions/peptide identifications with MALDI-TOF MS, demonstrated that 
L1 was only found in the sample that was produced from the overexpression plasmid containing the L1 gene and 
the leader sequence. The overexpression plasmid containing the gene for L1 without the leader sequence (M-L1) 
produced no L1 in the periplasm of E. coli. SDS−PAGE gels of the boiled cell fractions from the cultures 
demonstrated that L1 was overexpressed at similar levels in both cultures (data not shown). This result 
demonstrates that the S. maltophilia leader sequence can be recognized by E. coli and directs L1 for export in 
the periplasm. 
 
Figure 1. Localization of L1 produced in cells that contain the L1 gene and the leader sequence (FL-L1) and the L1 
gene without the leader sequence (M-L1). (A) SDS−PAGE gel of periplasmic fractions of (left) E. coli cells 
containing the gene for FL-L1 and (right) E. coli cells containing the gene for M-L1. The arrow marks the band for 
L1. (B, C) Antibiotic selection assay. (B) E. coli cells on a LB−kanamycin plate containing the gene for L1 and the 
leader sequence. (C) E. coli cells on a LB−kanamycin plate containing the gene for L1 without the leader 
sequence. The white dots are the disks containing 10 μg of ampicillin. 
 
To confirm this result, an antibiotic sensitivity assay was conducted. E. coli cells containing the overexpression 
plasmids for M-L1 (Figure 1B) and FL-L1 (Figure 1C) were plated on LB plates containing kanamycin. Disks 
containing 10 μg of ampicillin were placed on the plates, and the Petri dishes were incubated at 37 °C for 16 h. 
The E. coli cells containing the gene for FL-L1 in pET26b grew well in the presence of ampicillin; however, those 
cells containing the gene for M-L1 in pET26b did not grow in the area near the disk containing ampicillin. Since 
ampicillin imparts its antibacterial activity in the periplasm, this result demonstrates that E. coli containing the 
gene for FL-L1 exports L1 into the periplasm of the cell, while E. coli containing the gene for M-L1 does not. 
Characterization of M-L1 and FL-L1 
M-L1 and FL-L1 were overexpressed and purified as described by Crowder et al. (19). As previously 
reported (19), purified FL-L1, which was overexpressed in LB medium, contained 1.9 equiv of Zn(II) and exhibited 
steady-state kinetic constants of Km = 4 μM and kcat = 26 s−1 when using nitrocefin as the substrate (Table 1). In 
contrast, M-L1, which was overexpressed in LB medium, bound 0.7 equiv of Fe and 0.6 equiv of Zn(II) (Table 2). 
This enzyme exhibited a kcat of 10 s−1 and a Km of 1.0 μM when using nitrocefin as substrate. Clearly, the metal 
content of L1 is greatly affected by where the protein is localized. 
Table 1. Steady-State Kinetic and Metal Content Data for FL-L1a 
enzyme kcat (s−1) Km (μM) metal content (equiv) 
FL-L1 with Mnb 13 ± 1 5 ± 1 0.3 Mn/0.4 Fe/0.6 Zn(II) 
FL-L1 with Zn(II)b 28 ± 2 6 ± 1 0.1 Fe/1.9 Zn(II) 
FL-L1 with Feb 3.6 ± 0.1 6 ± 1 0.9 Fe/0.3 Zn(II) 
FL-L1 in LB mediumc 26 ± 1 4 ± 1 1.9 ± 0.1 Zn(II) 
FL-L1 in minimal mediumc 10 ± 1 4 ± 1 0.4 Fe/0.3 Zn(II) 
aSubstrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in 
Materials and Methods. 
bL1 was overexpressed in minimal medium containing 50 μM of the indicated metal ion as described in Materials 
and Methods. 
cL1 was overexpressed in minimal or LB medium without adding any additional metal ions. 
 
Table 2. Steady-State Kinetic and Metal Content Data for L1 Folded in the Cytoplasm (M-L1)a 
enzyme kcat (s−1) Km (μM) metal content (equiv) 
M-L1 with Mn(II)b 4.2 ± 0.4 2.1 ± 0.9 0.4 Mn; 0.4 Zn; 0.4 Fe 
M-L1 with Zn(II)b 21 ± 1 7.0 ± 1.1 0.3 Fe; 1.2 Zn(II) 
M-L1 with Fe(II)b <0.1 N/A 1.5 Fe; 0.1 Zn(II) 
M-L1 in minimal mediumc <0.1 N/A 0.2 Mn; 0.7 Fe; 0.1 Zn(II) 
M-L1 in LB mediumc 10 ± 1 1.0 ± 0.2 0.7 Fe; 0.6 Zn(II) 
aSubstrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in 
Materials and Methods. 
bL1 was overexpressed in minimal medium containing 50 μM of the indicated metal ion as described in Materials 
and Methods. 
cL1 was overexpressed in minimal or LB medium without adding any additional metal ions. 
 
To probe further the relationship where a protein is localized and the resulting metal content of the purified 
protein, FL-L1 and M-L1 were overexpressed in minimal medium in the presence of iron, zinc, or manganese. As 
a control, the proteins were also overexpressed in minimal medium that had no added metal ions. When the 
two proteins were overexpressed in minimal medium in the absence of added metal ions, FL-L1 contained 0.4 
equiv of Fe and 0.3 equiv of Zn(II) and exhibited a kcat of 10 s−1 and a Km of 4 μM (Table 1), while M-L1 contained 
0.2 equiv of Mn, 0.7 equiv of Fe, and 0.1 equiv of Zn(II) and exhibited no measurable catalytic activity (Table 2). 
From minimal medium containing 50 μM Zn(II), FL-L1 contained 1.9 equiv of Zn(II) and 0.1 equiv of Fe and 
exhibited a kcat of 28 s−1 and a Km of 6 μM (Table 1), while M-L1 contained 0.3 equiv of Fe and 1.2 equiv of Zn(II) 
and exhibited a kcat of 21 s−1 and a Km of 7 μM (Table 2). From minimal medium that was made 50 μM in Fe(II), 
FL-L1 contained 0.9 equiv of Fe and 0.3 equiv of Zn(II) and exhibited a kcat of 3.6 s−1 and a Km of 6 μM (Table 1), 
while M-L1 contained 1.5 equiv of Fe and 0.1 equiv of Zn(II) and exhibited no measureable catalytic activity 
(Table 2). Lastly, from minimal medium containing 50 μM Mn, FL-L1 contained 0.3 equiv of Mn, 0.4 equiv of Fe, 
and 0.6 equiv of Zn(II) and exhibited a kcat of 13 s−1 and a Km of 5 μM (Table 1), while M-L1 contained 0.4 equiv of 
Mn, 0.4 equiv of Zn(II), and 0.4 equiv of Fe and exhibited a kcat of 4.2 s−1 and a Km of 2.1 μM (Table 2). Mβl L1 can 
bind a number of different metal ions, and the final metal content depends greatly on whether the protein is 
exported and localized in the periplasm or whether it is localized in the cytoplasm. 
Refolding L1 in the Presence of Different Divalent Metal Ions 
The biological incorporation of metal ion experiments described above suggests that the bioavailability of metal 
ions has a large effect on the metal content of L1 after purification. Even though the steady-state kinetic studies 
demonstrated that L1 localized in the cytoplasm does have catalytic activity when bound to Zn(II), it is possible 
that the different metal content of the M-L1 and FL-L1 may be due to different folding mechanisms in the 
periplasm and cytoplasm. In an effort to probe whether bioavailability of metal ions does in fact affect metal 
content, in vitro unfolding/refolding experiments were conducted. 
Purified, apo-L1 was unfolded in the presence of 6 M Gdn-HCl and refolded in the presence of 50 μM Fe(II), 
Mn(II), Zn(II), and Fe(II)/Zn(II) (Table 3). L1 refolded in the presence of Zn(II) was shown to bind 2 equiv of Zn(II) 
and exhibited steady-state kinetic constants of kcat = 37 ± 1 s−1 and Km = 3.5 ± 0.2 μM when using nitrocefin as 
substrate (Table 3). These values are very similar to those of FL-L1 (Table 1). L1 refolded in the presence of Fe(II) 
resulted in an protein that binds 2 equiv of iron; however, the protein exhibited no catalytic activity. L1 refolded 
in the presence of Mn(II) did not bind its full complement of metal (only 0.2 equiv), and this protein also did not 
exhibit any catalytic activity. Since both Zn(II) and Fe appear to bind well to L1, we conducted a competition 
study in which L1 (20 μM) was refolded in the presence of equimolar amounts (50 μM) of Fe(II) and Zn(II). The 
resulting enzyme was shown to bind 1.5 equiv of Zn(II) and 0.4 equiv of Fe and exhibited steady-state kinetic 
constants of kcat = 28 ± 1 s−1 and Km of 3.0 ± 0.2 μM. This result demonstrates that L1 “prefers” Zn(II) binding but 
can also bind Fe. 
Table 3. L1 Refolded in the Presence of Fe(II), Zn(II), and Mn(II)a 
enzyme refolded kcat (s−1) Km (μM) metal content (equiv) 
with Zn(II) 37 ± 1 3.5 ± 0.2 2.0 ± 0.1 Zn 
with Fe(II) <0.1 N/A 2.0 ± 0.1 Fe 
with Mn(II) <0.1 N/A 0.20 ± 0.05 Mn 
with Zn(II) + Fe(II) 28 ± 1 3.0 ± 0.2 1.5 ± 0.1 Zn, 0.4 ± 0.1 Fe 
aSubstrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in 
Materials and Methods. 
 
EPR Studies on Fe-Containing Forms of L1 
EPR spectra of as-isolated M-L1, containing 0.7 equiv of Fe and 0.6 equiv of Zn(II), exhibited typical temperature-
dependent features at geff values of 9.3 (745 G, 74.5 mT) and 4.3 (1616 G, 161.6 mT) due to transitions in the 
ground state and middle Kramers’ doublets, respectively, of S = 5/2 Fe(III) (Figure 2A). An additional signal was 
observed with geff < 2.0 and was assigned to an Fe(II)Fe(III) species on the basis of the similarity of the signal to 
one from glyoxalase 2−5 (16). Similar signals have been reported for uteroferrin and mammalian purple acid 
phosphatases (26, 27). This signal in M-L1 exhibited a complex temperature and power dependence and was 
optimally developed at 10−12 K. Difference analysis indicated that the g < 2 signal was due to at least two 
discrete but extremely similar species with slightly different spin Hamiltonian and relaxation parameters, due 
either to discrete [Fea(II)Feb(III)] and [Fea(III)Feb(II)] species or to structural microheterogeneity. EPR of L1 that 
was refolded in the presence of Fe(II) showed the same sets of S = 1/2 and S = 5/2 signals but in very different 
proportions (Figure 2B). Because of the complex temperature dependence of the S = 1/2 signal and because of 
the inherent complexity of the S = 5/2 “geff = 4.3” system (28), results of attempts at quantitation should be 
treated with some caution; for signals of the quality obtained, an error of ±5% in spin concentration is expected, 
and an additional error due to uncertainty in the respective zero-field splittings in the species is estimated be 
±5%, leading to an overall error of ±10%. Nevertheless, the results of quantitation are enlightening as a 
comparison tool. The EPR signal from as-isolated M-L1, containing both Fe and Zn(II), was estimated to be due to 
a 45 ± 5% contribution of the Fe(III) signal and a 55 ± 5% contribution of the Fe(II)Fe(III) signal. In contrast, L1 
refolded in the presence of iron exhibited a spectrum with >90% spin density due to the Fe(II)Fe(III) signal and 
only 6−8% due to isolated S = 5/2 Fe(III). The total spin density of the refolded L1 corresponded to 0.8 equiv of 
spins and, therefore, suggests that 0.8 × 90% ∼ 70% of the molecules contained an Fe(II)Fe(III) center. This, in 
turn, suggests an overall Fe content of ∼1.55 ± 0.15 Fe/mol, which is in very good agreement with the analytical 
value of 1.5 equiv of Fe/mol. Efforts to collect 1H NMR spectra of the iron-containing L1 samples have not been 
successful as the proteins are not stable and precipitate during acquisition times. 
 
Figure 2. (A) EPR spectra of as-isolated M-L1 recorded at 5.6 K, 63 mW (filled line), 12 K, 63 mW (dotted line), 
and 12 K, 10 mW (dashed line). Various regions of the spectrum are shown to highlight the different behaviors 
as a function of temperature and microwave power. (B) EPR spectrum of as-isolated L1, “FeZn-L1” (dotted line, 
12 K, 10 mW), and that of L1 refolded in the presence of iron, “Fe-L1” (filled line; 10 mW, 10 K). 
 
Zn(II) and Fe Content in E. coli 
The studies above strongly suggest that the metal content of L1 is determined by the bioavailability of Fe and 
Zn(II) where the protein is folded/localized. In an effort to evaluate the amount of Fe and Zn(II) in the periplasm 
and cytoplasm of E. coli cells, we conducted metal analyses on the periplasmic and cytoplasmic fractions of E. 
coli cells grown in minimal medium containing no additional metal ions and containing 100 μM Zn(II) or Fe. The 
amount of Zn(II) and Fe in the soluble portion of the cytoplasm of E. coli cells cultured in the absence of added 
metal ions is ca. 45 μM for both metal ions. If the cells are cultured in minimal medium containing 100 μM Zn(II) 
or Fe, the amount of Zn(II) in the cytoplasm remains at 45 μM, while the amount of Fe increases 3-fold to about 
153 μM. In the soluble periplasmic fractions, the amount of Zn(II) and Fe from cells cultured in the absence of 
added metal ion is <1 μM. In the soluble periplasmic fraction of cells cultured in the presence of Zn(II) and Fe, 
the amount of Zn(II) increased >10-fold to 1.23 mM, while the amount of Fe increased >20-fold to 2.83 mM. The 
bioavailability of Zn(II) in the periplasm and the preference for Zn(II) binding to FL-L1 leads then to the 
preparation of ZnZn-L1 when the protein is overexpressed in medium containing enough Zn(II). In the absence of 
enough Zn(II), Fe can bind to L1 (in the cytoplasm and in the samples overexpressed with added Fe). 
Discussion 
While the number of Zn(II) ions physiologically bound to mβl’s is under debate (29-33), there is universal 
agreement that Zn(II) is the metal ion bound to these enzymes in vivo. Nonetheless, several groups have 
reported spectroscopic studies using Co(II) and Cd(II) analogues (29, 34-39) (both metal ions are excellent 
surrogates of Zn(II)) of several mβl’s, and early papers on several mβl’s reported activation of apoenzymes by 
manganese, iron, and other metal ions (40, 41). A recent paper by Vila and co-workers reports the binding of Fe 
to GOB-1 from E. meningoseptica, although the resulting enzyme was catalytically inactive (33). Page and co-
workers recently reported that manganese-substituted BcII exhibited catalytic activity (42). Since mβl’s are 
enzymes that confer resistance to antimicrobial agents, it seems reasonable that the activation of these 
enzymes by different metal ions, particularly in environments that lack sufficient quantities of Zn(II), would be 
beneficial to the organism. There certainly is precedence in the literature for Zn(II) binding sites in Zn(II) 
metalloenzymes being able to bind a number of different metal ions (14, 15), and a large of number of studies 
on metal-substituted aminopeptidase from A. proteolytica have been reported (43-47). Nonetheless, it is not 
clear that many of these metal-substituted enzymes are physiologically relevant. In the present study, we were 
interested in determining whether the metal content of mβl L1 is affected by where the protein is 
folded/metallated/localized. 
We, therefore, prepared overexpression constructs that contained the full-length gene for L1 (leader sequence 
plus gene for L1, FL-L1) or that contained only the gene for L1 (no leader sequence, M-L1) and used these 
plasmids to overexpress L1. Our first task was to determine where L1 was localized in E. coli after protein 
production, and our data clearly show that L1 produced from the FL-L1 plasmid is exported into the periplasm, 
while L1 produced from the M-L1 plasmid is in the cytoplasm. The overexpression and localization of L1 in the 
cytoplasm without a fusion peptide/protein are the first examples of a mature mβl being produced and localized 
in the cytoplasm. Biochemical analyses of the two enzymes when overexpressed in rich medium clearly show 
that the two enzymes are different, with FL-L1 binding only Zn(II) and M-L1 binding nearly equal amounts of Fe 
and Zn(II). This latter result is similar to results previously reported for recombinant glyoxalase II, which is a 
member of the β-lactamase superfamily of proteins (14, 15) and is overexpressed and localized in the cytoplasm 
of E. coli. 
The export of L1 into the periplasm could be accomplished by at least two different pathways. The first pathway 
is the TAT system in E. coli, which transfers fully folded proteins from the cytoplasm into the periplasm (48). This 
system requires the presence of an Arg-rich sequence in the protein that serves as a signaling sequence. Given 
that L1 does not have this Arg-rich sequence (25) and that M-L1 and FL-L1 bind different metal ions, it is highly 
unlikely that L1 is transported as a folded, metallated protein via the TAT system. The second major transport 
system is the Sec system, which has been studied in detail (49). The Sec system exports unfolded proteins, and 
therefore once in the periplasm, the periplasmic protein must be folded by folding proteins in the periplasm. 
Moreover, periplasmic proteins must be metalated in the periplasm, and the metal content data presented in 
this work support this pathway in use by L1. 
To further probe how the metal content of L1 is affected by where the protein is folded and metalated, we 
overexpressed and purified M-L1 and FL-L1 from minimal medium containing Fe, Zn(II), or Mn. The resulting 
proteins contained different amounts of metal ions and exhibited different kinetic properties. The amount of 
metal available for metalation of L1 is determined by the amount of the metal in the growth medium, no matter 
if the protein is folded in the periplasm or cytoplasm. While the increase in bioavailability of a metal ion in the 
periplasm as the metal concentration of the medium goes up was expected, the increase in bioavailable metal in 
the cytoplasm was unexpected. All cells have elaborate homeostatic pathways that presumably maintain metal 
ion concentrations in a very narrow range of concentrations (50-52). For example, the cytoplasmic 
concentrations of Zn(II) are maintained by importers ZnuABC and ZupT and exporters ZitB and ZntA (53). Metal 
analyses of the soluble periplasmic and cytoplasmic fractions of E. coli demonstrate that the concentrations of 
metal ions in both fractions increase with increasing levels (only slightly so for Zn(II)) of the metal ion in the 
growth medium. The relatively higher increase in cytoplasmic Fe levels may be due to the cell’s better ability to 
store Fe rather than Zn(II) in bacterioferritin (54). The preparation of L1 that was folded and metalated in the 
cytoplasm contains a different metal content, and this result indicates that caution should be exercised when 
recombinant metalloproteins are overexpressed. Ideally, overexpression constructs should be made so that 
bacterial metalloproteins will be overexpressed and folded in the same place in E. coli as they are folded in the 
original organism. When overexpressing eukaryotic metalloproteins in E. coli, overexpression constructs should 
be designed to fold/metalate the protein in the cytoplasm, periplasm, and/or possible in the extracellular 
environment (using a pelB leader for example) so that the possibility of different metal content of the resulting 
protein can be evaluated. 
The overexpression of M-L1 in the cytoplasm yielded an analogue of L1 that contains nearly equimolar 
concentrations of Fe and Zn(II). Given the trihistidine site in the Zn1 site of L1 (13), it was predicted that this 
enzyme was a FeZn analogue of L1; however, EPR studies demonstrated that there is a mixture of metal centers 
in this sample including a spin-coupled Fe(III)Fe(II) center and a Fe(III)Zn(II) center. Our ability to refold L1 in the 
presence of Zn(II) and/or Fe allowed for us to obtain metal-enriched forms of L1. These data clearly show that 
the FeFe analogue of L1 is inactive, possibly due to Asp120 bridging the metal centers (55, 56), which is probably 
required for the observed antiferromagnetic coupling between the Fe ions (57), and not being available to form 
an essential hydrogen bond with the bridging hydroxide (55). It is not clear from our data whether the 
Fe(III)Zn(II) analogue of L1 is catalytically active, but the refolding of L1 in the presence of equimolar 
concentrations of Fe and Zn(II) clearly shows a preference for Zn(II) binding to L1. Future studies will address 
whether the Fe(III)Zn(II) analogue of L1 is catalytically active. 
Taken together, this work demonstrates that the metal content of L1 depends strongly on bioavailability of 
metal ions where the protein is folded. This result will aid in the preparation of metal-substituted 
metalloproteins to study the structure/function of these proteins. 
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